<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26874">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02082015</url>
  </required_header>
  <id_info>
    <org_study_id>E-1308-214-002</org_study_id>
    <nct_id>NCT02082015</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study of rTMS for Upper Extremity Motor Function Recovery in Ischemic Stroke Patients</brief_title>
  <acronym>TAMAS</acronym>
  <official_title>A Randomized, Double-Blind, Sham-Controlled, Multi-center Clinical Trial to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients With Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DongGuk University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper
      Extremity Motor Function Recovery in Patients with Ischemic Stroke
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Repetitive transcranial magnetic stimulation (rTMS) can modulate the excitability of cortex
      but exact efficacy and safety of rTMS is not well established.

      Eighty four patients will be recruited and will be divided into two groups. Each group will
      receive the real rTMS or sham rTMS, respectively, over the primary motor cortex of the
      dominant hand. Individual subject will receive ten sessions of rTMS. Each rTMS session is
      low frequency (1Hz), total 1800 stimulations.

      The purpose of this study is to evaluate efficacy and safety of rTMS 『TMS』 for upper
      extremity motor function recovery in patients with ischemic stroke.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Box and Block Test (affected hand)</measure>
    <time_frame>up to 17 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Before rTMS (baseline) and 10 days after the completion of 10 sessions of rTMS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Box and Block Test (Affected and unaffected hand)</measure>
    <time_frame>up to 40 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Before rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>up to 40 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institutes of Health Stroke Scale</measure>
    <time_frame>up to 40 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Assessment Scale</measure>
    <time_frame>up to 40 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Vital Sign</measure>
    <time_frame>up to 40 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Before rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Stroke</condition>
  <condition>Hemiplegia</condition>
  <arm_group>
    <arm_group_label>true coil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use the true coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham coil</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Use the sham coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low frequency rTMS</intervention_name>
    <description>Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp</description>
    <arm_group_label>true coil</arm_group_label>
    <arm_group_label>sham coil</arm_group_label>
    <other_name>Magpro (low frequency)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-80 yrs old

          -  Radiologically confirmed ischemic stroke within 90 days

          -  Brunnström stage 3-5 in the affected hand (ischemic stroke-induced hemiplegic side)

          -  Patients received stroke treatment and on secondary prevention medication

          -  Written informed consent

        Exclusion Criteria:

          -  Previous medical histories of stroke, cerebral vascular operation, seizure

          -  Pregnancy, Breastfeeding

          -  Patients with hemorrhagic stroke, traumatic brain injury

          -  Skin lesion in the stimulation site of scalp

          -  Metal implants in the body (cardiac pacemaker or aneurysm clip)

          -  Unable to have regular physical and occupational therapies on the affected hand
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nam-Jong Paik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>March 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Nam-Jong Paik</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Neuronal plasticity</keyword>
  <keyword>Transcranial magnetic stimulation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Upper extremity</keyword>
  <keyword>Function</keyword>
  <keyword>Recovery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemiplegia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
